Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aldiamed
2. Hydroxyethylcellulose
3. Hydroxyethylcellulose, Sodium Salt
4. Hydroxyl Ethyl Cellulose
5. Lacrigel
6. Minims Artificial Tears
7. Natrosol 250
1. Hetastarch
2. 9004-62-0
3. 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol
4. 2-hydroxyethyl Cellulose
5. Hydroxyethyl-cellulose
6. Schembl23306563
7. Dtxsid60873934
8. Ft-0627136
9. H11622
10. 2-hydroxyethyl Cellulose; Cellulose Hydroxyethyl Ether
11. 2-o-(2-hydroxyethyl)-4-o-methylhexopyranosyl-(1->4)-[4-o-methylhexopyranosyl-(1->6)]hexopyranosyl-(1->5)-2,6-anhydro-1-deoxyheptitol
Molecular Weight | 736.7 g/mol |
---|---|
Molecular Formula | C29H52O21 |
XLogP3 | -7.7 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 15 |
Exact Mass | 736.30010866 g/mol |
Monoisotopic Mass | 736.30010866 g/mol |
Topological Polar Surface Area | 315 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 999 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 20 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
NDC Package Code : 18124-009
Start Marketing Date : 1995-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 18124-009
Start Marketing Date : 1995-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
ABOUT THIS PAGE
67
PharmaCompass offers a list of Hetastarch API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hetastarch manufacturer or Hetastarch supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hetastarch manufacturer or Hetastarch supplier.
PharmaCompass also assists you with knowing the Hetastarch API Price utilized in the formulation of products. Hetastarch API Price is not always fixed or binding as the Hetastarch Price is obtained through a variety of data sources. The Hetastarch Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hespan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hespan, including repackagers and relabelers. The FDA regulates Hespan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hespan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hespan supplier is an individual or a company that provides Hespan active pharmaceutical ingredient (API) or Hespan finished formulations upon request. The Hespan suppliers may include Hespan API manufacturers, exporters, distributors and traders.
click here to find a list of Hespan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hespan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hespan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hespan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hespan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hespan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hespan suppliers with NDC on PharmaCompass.
Hespan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hespan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hespan GMP manufacturer or Hespan GMP API supplier for your needs.
A Hespan CoA (Certificate of Analysis) is a formal document that attests to Hespan's compliance with Hespan specifications and serves as a tool for batch-level quality control.
Hespan CoA mostly includes findings from lab analyses of a specific batch. For each Hespan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hespan may be tested according to a variety of international standards, such as European Pharmacopoeia (Hespan EP), Hespan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hespan USP).